23 October 2013
INVESTOR EVENT
On Monday 18th November 2013, Silence Therapeutics is hosting an Investor event for investors and analysts in London. The purpose of the event is to explain the background to Silence's technology and outline its potential. No material new information will be presented.
For further information please contact:
Silence Therapeutics plc
Timothy Freeborn, finance director
Annie Cheng, director of corporate development
+44 (0)333 988 0140
[email protected]
[email protected]
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3000
[email protected]
[email protected]